Industry News
Trajan joins BioMelbourne Network
Trajan Scientific and Medical is now a member of BioMelbourne Network, an industry forum for the leaders of the Victorian biotechnology industry. [ + ]
New website to chronicle Australians' engagement in science
From today, Australian communication researchers will be able to monitor more closely what science Australians are being exposed to, with the launch of a new website chronicling science engagement activities across the country. [ + ]
New 3D imaging technology keeps long samples intact
Researchers at the Universidad Carlos III of Madrid (UC3M) and its spin-off company, 4D-Nature, have developed a technique called helical optical projection tomography (hOPT), which improves biomedical diagnostic 3D imaging. [ + ]
Phase 1 of Admedus HSV-2 trial achieves primary endpoint
Admedus (ASX:AHX) has announced interim study results on its phase 1 trial of a therapeutic vaccine for herpes simplex virus (HSV-2). [ + ]
Seminal fluid shapes health of offspring
Researchers from the University of Adelaide's Robinson Institute have discovered that a man's seminal fluid plays a major role in various developmental stages of his offspring, including future health conditions. Their research has been published in Proceedings of the National Academy of Sciences. [ + ]
Seeing like a satellite
The eyes of mantis shrimp have a unique, previously undocumented colour vision system that uses 12 different types of photoreceptors. [ + ]
Mesoblast's MPCs reduce back pain in phase II trial
Patients with low back pain from early disc degeneration treated with Mesoblast (ASX:MSB) MPCs during a phase II trial reported reduced back pain and required fewer pain drugs compared to controls. [ + ]
Medtech event of the year open for registration
The annual AusMedtech national conference will again be held in Melbourne, from 1-2 April at the Hilton on the Park. The flagship medical technology event of the year has just confirmed Mick Farrell, CEO of ResMed, to speak on day one. [ + ]
Access to medical isotopes
Australian researchers and clinicians can now access locally produced medical isotopes thanks to a new collaborative arrangement. [ + ]
Drawbridge wins patents for anaesthesia candidate
Drawbridge Pharmaceuticals has picked up patents in six countries for Phaxan, its anaesthesia drug candidate that entered the phase IC trial stage this month. [ + ]
Viralytics to raise up to $27m for cancer trials
Viralytics (ASX:VLA) has launched a capital raising to secure funds for clinical trials of cancer treatment candidate Cavatak in melanoma and other solid tumours. [ + ]
Qiagen submits C. difficile assay to FDA
Qiagen plans to roll out a portfolio of assays for the QIAsymphony platform to aid in the diagnosis of healthcare-associated infections (HAIs). The company's first new test, the artus C. difficile QS-RGQ MDx Kit, has been submitted to the US Food and Drug Administration (FDA). [ + ]
Burnet Institute to roll out cheap point-of-care HIV test
Burnet Institute has received US$1.6 million from UNITAID to begin evaluation studies of HIV test VISITECT CD4 in India and South Africa. The point-of-care test uses a small amount of blood from a finger prick to determine when an HIV-positive patient should start lifesaving treatment. Results of the test are available after 40 min at a cost of approximately $5. [ + ]
Spinning cloth disc reactor accelerates enzyme reactions
Researchers from the University of Bath have developed a new enzymatic process intensification technology - the 'spinning cloth disc reactor' (SCDR) - which is one of only a few technologies available for accelerating the rate of an enzyme reaction. [ + ]
Nanoparticles provide a new way to treat heart attack
Researchers are recruiting nanobiology to change the way heart attacks are treated. [ + ]
